Project Grant K23AA033193
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Colorado-Denver $191,592 on August 19, 2026, under the Alcohol Research Programs (CFDA 93.273) to support a five-year mentored research project on enhancing emergency department care for alcohol use disorder. Dr. Jacob Lebin will develop and test an electronic health record-embedded clinical decision support tool designed to improve identification and treatment of alcohol use disorder in emergency department...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Regents Of The University Of Colorado (doing business as University Of Colorado-Denver) $191,509 on August 20, 2026, under the Alcohol Research Programs (CFDA 93.273) to adapt and pilot test a care navigation intervention for hospitalized patients with alcohol use disorder. The award funds adaptation and pilot testing of the Navigation for Prioritized Alcohol Treatment After Hospitalization (NAVPATH) intervention, which...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Regents of the University of California, San Francisco $203,036 on July 9, 2026, under the Alcohol Research Programs (CFDA 93.273) to support a mentored patient-oriented research career development project (K23) led by Dr. Natalia Van Doren. The award funds a mobile mindfulness-based intervention for unhealthy alcohol use in people with anxiety, combining integrated training and research activities. Dr. Van Doren will receive...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Regents of the University of Colorado, doing business as University of Colorado-Denver, $587,958 on August 10, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct a longitudinal sibling-comparison study of alcohol use disorder and co-occurring externalizing problems in high-risk individuals. The research follows 559 mid-adulthood participants with high prevalence of alcohol use disorder (67%), arrest history for...
- The National Institute on Alcohol Abuse and Alcoholism awarded Denver Health and Hospital Authority $189,000 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to support a project grant for ketamine therapy research in alcohol use disorder. Principal investigator Dale Terasaki, MD, MPH, an addiction medicine specialist at Denver Health, will conduct a hospital-based clinical trial and real-world outcomes study of ketamine as a pharmacotherapy for alcohol use disorder...
- The National Institute on Alcohol Abuse and Alcoholism awarded Beth Israel Deaconess Medical Center, Inc. $177,736 on August 17, 2026, under the Alcohol Research Programs (CFDA 93.273) to support a postdoctoral researcher's career development in understanding the role of neutrophil extracellular traps (NETs) in alcohol-induced acute-on-chronic liver failure. The award funds a two-year mentored research program spanning August 17, 2026, through July 31, 2028, based in Boston, Massachusetts. The...
- The National Institute on Alcohol Abuse and Alcoholism awarded The General Hospital Corporation (Massachusetts General Hospital) $395,079 on September 10, 2025, under the Alcohol Research Programs (CFDA 93.273) for a mentored patient-oriented research career development award. The award funds a study evaluating the feasibility, acceptability, and preliminary clinical utility of measuring dyadic relational processes during early recovery from alcohol use disorder using ecological momentary...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Medical University of South Carolina $211,659 on August 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to support a K23 Mentored Patient-Oriented Research Career Development Award funding Dr. Margaret Baer's research program. Dr. Baer will develop a novel single-session intervention for alcohol craving and suicide ideation, then conduct a micro-randomized clinical trial to generate preliminary evidence on the most...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Regents of the University of Colorado, doing business as University of Colorado-Denver, $140,340 on December 1, 2025, under the Alcohol Research Programs (CFDA 93.273) for a Project Grant investigating the role of the C5 complosome in ethanol-induced immunometabolic dysregulation of Kupffer cells in alcohol-associated liver disease. The funded research defines novel mechanisms of alcohol-induced metabolic reprogramming of Kupffer...
- The National Institute on Alcohol Abuse and Alcoholism awarded Loyola University of Chicago Health Sciences Campus $115,500 on August 17, 2026, under the Alcohol Research Programs (CFDA 93.273) to identify leading causes and pathways of death in alcoholic acute respiratory distress syndrome (ARDS) patients through computational analysis of clinical trial datasets. The recipient will conduct a retrospective cohort study validating findings across five NIH-funded, multicenter, randomized,...
The National Institute on Alcohol Abuse and Alcoholism awarded the University of Colorado-Denver $189,532 on August 19, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop and test a peer-narrated video decision aid for alcohol treatment tailored to intensive care unit survivors with alcohol use disorder. The award funds a five-year career development project (K23) led by Dr. Kelsey Hills-Dunlap. The research addresses a gap identified in prior work: ICU survivors with alcohol use disorder often make uninformed treatment decisions at discharge despite hospitalization representing a motivational "teachable moment" for behavior change. The decision aid, narrated by peers, aims to provide structured, accessible treatment decision support for this population. The project will include rigorous testing and refinement of the decision aid, preparation for future implementation, and completion of a Master of Science in Clinical Science with coursework in dissemination and implementation science. Dr. Hills-Dunlap will receive mentorship from a multidisciplinary team led by Dr. Ellen Burnham, an expert in alcohol and critical care clinical research, and Dr. Dan Matlock, a national leader in decision aid development and implementation science. The training plan encompasses foundational knowledge in addiction science, advanced skills in mixed methods and missing data analysis, and experience designing and conducting pragmatic clinical trials involving ICU survivors with alcohol use disorder. Performance occurs in Aurora, Colorado, with a period of performance through July 31, 2031. This is a Project Grant, an assistance type under NIAAA's alcohol research portfolio supporting development of improved treatment methods and prevention strategies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $189.5k | 8/21/26 |